Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-18-054519

Chief Operating Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hogenhuis Wladimir · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-04 Grant or award : show line 1 in the form +15,000 15,000 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-10-04 Grant or award : show line 2 in the form Stock Option (Right to Buy) +75,000 $77.30 2028-10-04 75,000 75,000 D
Loading xslF345X03/doc4.xml…